Erbitux-MHT-71

N/A

Report date: 2025/03/20 15:44:18

Base Information

Drug NameErbitux-MHT-71
Drug Alias Nameantibody-drug conjugate (Industrial Technology Research Institute)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndustrial Technology Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesIndustrial Technology Research Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A